Myeong Chan Park
Papers
1
Total Citations
10
H-Index
1
About
Dr. Myeong Chan Park is a distinguished urologic surgeon and researcher whose work centers on the management of renal tumors, with a particular focus on large angiomyolipomas (AMLs). His major contribution lies in directly comparing the efficacy and safety of selective arterial embolization (SAE) against robotic-assisted nephron-sparing surgery (NSS) for these complex, benign tumors. In his pivotal 2021 study, Dr. Park demonstrated that while both treatments are viable, robotic NSS offers superior outcomes in terms of lower recurrence rates and reduced need for re-intervention, providing crucial guidance for clinical decision-making. This work, which has garnered 10 citations, has helped shape modern treatment paradigms for large AMLs, emphasizing the importance of nephron preservation. Dr. Park’s research is characterized by its practical, patient-centered approach, offering clear, evidence-based recommendations that directly impact surgical practice and improve long-term patient outcomes in the field of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1